Prof. Dr. Raja Atreya

Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen

Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice with Chronic Intestinal Inflammation (2018) Scheibe K, Kersten C, Schmied A, Vieth M, Primbs T, Carlé BE, Knieling F, et al. Journal article IL-23 is centrally involved in mediating molecular resistance to anti-TNF therapy in Crohn's disease patients (2018) Schmitt H, Billmeier U, Dieterich W, Rath T, Sonnewald S, Reid S, Hirschmann S, et al. Conference contribution Hobit- and Blimp1-driven tissue resident memory T cells critically control chronic intestinal inflammation (2018) Zundler S, Becker E, Spocinska M, Parga-Vidal L, Stark R, Atreya R, Rath T, et al. Conference contribution IL-3 drives IL-10-secreting Tr1 cells to counteract experimental colitis (2018) Zundler S, Spocinska M, Popp V, Becker E, Atreya R, Neufert C, Atreya I, et al. Conference contribution Clinical efficacy of the Toll-like receptor 9 agonist cobitolimod using patient-reported-outcomes defined clinical endpoints in patients with ulcerative colitis (2018) Atreya R, Reinisch W, Peyrin-Biroulet L, Scaldaferri F, Admyre C, Knittel T, Kowalski J, et al. Journal article Crohn's Disease: Improved Treatment by Treat-to-Target-Concept Comment (2018) Atreya R Journal article Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel Disease (2018) Koelink PJ, Wildenberg ME, Stitt LW, Feagan BG, Koldijk M, Van 'T Wout AB, Atreya R, et al. Journal article Clinical outcomes and immunogenicity analysis over 6 months following a switch from originator infliximab (Remicade (R)) to the biosimilar SB2 (Flixabi (R)) in inflammatory bowel disease patients (2018) Fischer SM, Klenske E, Schmitt H, Vitali F, Hirschmann S, Koch F, Ramming A, et al. Conference contribution Alpha 4 beta 7 Integrin-dependent gut homing of non-classical monocytes is essential for intestinal wound healing mediated by M2 macrophages (2018) Schleier L, Wiendl M, Binder MT, Atreya R, Watson A, Neufert C, Atreya I, et al. Conference contribution The TLR9 agonist cobitolimod induces anti-inflammatory effects and balances the Th17/T-reg cell response in ulcerative colitis (2018) Schmitt H, Billmeier U, Ulmschneider J, Admyre C, Knittel T, Zargari A, Neurath M, Atreya R Conference contribution